{
  "x402Version": 2,
  "id": 39429,
  "slug": "39429",
  "resource": "https://api.magentlab.com/api/calc/nccn_ipi",
  "description": "Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bone marrow, CNS, liver/GI tract, or lung) 1, ECOG ≥2 1; max 8. Low 0–1, low_intermediate 2–3, high_intermediate 4–5, high 6–8. Deterministic published score; not a DLBCL diagnosis or treatment choice; not Shipp IPI, not R-IPI, not CNS-IPI. magent does not assay LDH or stage lymphoma.",
  "type": "http",
  "serviceName": "magent",
  "resourceType": "Agent Service",
  "accepts": [
    {
      "scheme": "exact",
      "network": "eip155:8453",
      "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "amount": "5000",
      "amountUsd": 0.005,
      "maxTimeoutSeconds": 600
    }
  ],
  "outputSchema": {
    "properties": {
      "example": {
        "type": "object"
      },
      "type": {
        "type": "string"
      }
    },
    "required": [
      "type"
    ],
    "type": "object"
  },
  "extensions": {
    "bazaar": {
      "info": {
        "iconUrl": "https://api.magentlab.com/favicon.ico",
        "input": {
          "body": {
            "items": [
              {
                "age": 40,
                "ecog": 0,
                "extranodal_major": false,
                "ldh_uln_ratio": 0.9,
                "stage_iii_or_iv": false
              },
              {
                "age": 40,
                "ecog": 0,
                "extranodal_major": false,
                "ldh_uln_ratio": 0.9,
                "stage_iii_or_iv": false
              }
            ]
          },
          "method": "POST",
          "type": "http"
        },
        "output": {
          "example": {
            "count": 2,
            "items": [
              {
                "age_years": 40,
                "citation": {
                  "authors": "Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN",
                  "doi": "10.1182/blood-2013-09-524108",
                  "id": "zhou-2014",
                  "pmid": "24264230",
                  "source": "Blood. 2014;123(6):837-842",
                  "title": "An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era"
                },
                "components": [
                  {
                    "factor": "age",
                    "points": 0,
                    "present": false,
                    "value": 40
                  },
                  {
                    "factor": "ldh_uln_ratio",
                    "points": 0,
                    "present": false,
                    "value": 0.9
                  },
                  {
                    "factor": "stage_iii_or_iv",
                    "points": 0,
                    "present": false
                  },
                  {
                    "factor": "extranodal_major",
                    "points": 0,
                    "present": false
                  },
                  {
                    "factor": "ecog_ge_2",
                    "points": 0,
                    "present": false,
                    "value": 0
                  }
                ],
                "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
                "ecog": 0,
                "extranodal_major": false,
                "formula": "nccn_ipi",
                "formula_expression": "NCCN-IPI = age (≤40 0, 41–60 1, 61–75 2, ≥76 3) + LDH/ULN (≤1 0, >1–3 1, >3 2) + stage_iii_or_iv 1 + extranodal_major 1 + ecog_ge_2 1; Zhou 2014; max 8; low 0-1, low_intermediate 2-3, high_intermediate 4-5, high 6-8",
                "ldh_uln_ratio": 0.9,
                "max_score": 8,
                "nccn_ipi_risk": "low",
                "score": 0
              },
              {
                "age_years": 40,
                "citation": {
                  "authors": "Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN",
                  "doi": "10.1182/blood-2013-09-524108",
                  "id": "zhou-2014",
                  "pmid": "24264230",
                  "source": "Blood. 2014;123(6):837-842",
                  "title": "An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era"
                },
                "components": [
                  {
                    "factor": "age",
                    "points": 0,
                    "present": false,
                    "value": 40
                  },
                  {
                    "factor": "ldh_uln_ratio",
                    "points": 0,
                    "present": false,
                    "value": 0.9
                  },
                  {
                    "factor": "stage_iii_or_iv",
                    "points": 0,
                    "present": false
                  },
                  {
                    "factor": "extranodal_major",
                    "points": 0,
                    "present": false
                  },
                  {
                    "factor": "ecog_ge_2",
                    "points": 0,
                    "present": false,
                    "value": 0
                  }
                ],
                "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
                "ecog": 0,
                "extranodal_major": false,
                "formula": "nccn_ipi",
                "formula_expression": "NCCN-IPI = age (≤40 0, 41–60 1, 61–75 2, ≥76 3) + LDH/ULN (≤1 0, >1–3 1, >3 2) + stage_iii_or_iv 1 + extranodal_major 1 + ecog_ge_2 1; Zhou 2014; max 8; low 0-1, low_intermediate 2-3, high_intermediate 4-5, high 6-8",
                "ldh_uln_ratio": 0.9,
                "max_score": 8,
                "nccn_ipi_risk": "low",
                "score": 0
              }
            ],
            "path": "/api/calc/nccn_ipi"
          },
          "type": "json"
        }
      },
      "schema": {
        "$schema": "https://json-schema.org/draft/2020-12/schema",
        "properties": {
          "input": {
            "additionalProperties": false,
            "properties": {
              "body": {
                "additionalProperties": false,
                "properties": {
                  "items": {
                    "items": {
                      "properties": {
                        "age": {
                          "description": "Age in years (18-120). ≤40 scores 0; 41–60 scores 1; 61–75 scores 2; ≥76 scores 3 (Zhou 2014 NCCN-IPI refined age). Age 40 scores 0; 41 and 60 score 1; 61 and 75 score 2; 76 scores 3. Not Shipp IPI binary >60.",
                          "type": "integer"
                        },
                        "ecog": {
                          "description": "ECOG performance status 0-4 as assigned by the caller (Zhou 2014 NCCN-IPI). ≥2 scores 1. magent does not assign ECOG.",
                          "type": "integer"
                        },
                        "extranodal_major": {
                          "description": "Extranodal involvement of major organs (bone marrow, CNS, liver/GI tract, or lung) as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. This is not IPI extranodal sites >1. magent does not image extranodal sites.",
                          "type": "boolean"
                        },
                        "ldh_uln_ratio": {
                          "description": "Serum LDH divided by the laboratory ULN (0.1-20). ≤1 scores 0; >1 and ≤3 scores 1; >3 scores 2 (Zhou 2014 NCCN-IPI). 1.0 scores 0; 1.01 and 3.0 score 1; 3.01 scores 2. magent does not assay LDH.",
                          "type": "number"
                        },
                        "stage_iii_or_iv": {
                          "description": "Ann Arbor stage III or IV as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. magent does not stage lymphoma.",
                          "type": "boolean"
                        }
                      },
                      "required": [
                        "age",
                        "ecog",
                        "ldh_uln_ratio",
                        "stage_iii_or_iv",
                        "extranodal_major"
                      ],
                      "type": "object"
                    },
                    "maxItems": 25,
                    "minItems": 1,
                    "type": "array"
                  }
                },
                "required": [
                  "items"
                ],
                "type": "object"
              },
              "headers": {
                "additionalProperties": {
                  "type": "string"
                },
                "type": "object"
              },
              "method": {
                "const": "POST",
                "type": "string"
              },
              "type": {
                "const": "http",
                "type": "string"
              }
            },
            "required": [
              "type",
              "method"
            ],
            "type": "object"
          },
          "output": {
            "properties": {
              "example": {
                "type": "object"
              },
              "type": {
                "type": "string"
              }
            },
            "required": [
              "type"
            ],
            "type": "object"
          }
        },
        "required": [
          "input"
        ],
        "type": "object"
      }
    }
  },
  "tags": [
    "nccn-ipi",
    "lymphoma",
    "hematology",
    "dlbcl",
    "prognosis",
    "bazaar"
  ],
  "sourceHost": "api.magentlab.com",
  "lastUpdated": "2026-10-12T14:54:20.834Z",
  "quality": {
    "calls30d": 4,
    "uniquePayers30d": 2,
    "lastCalledAt": "2026-10-12T14:54:20.695Z"
  },
  "metadata": {
    "serviceName": "magent",
    "extensions": {
      "bazaar": {
        "info": {
          "iconUrl": "https://api.magentlab.com/favicon.ico",
          "input": {
            "body": {
              "items": [
                {
                  "age": 40,
                  "ecog": 0,
                  "extranodal_major": false,
                  "ldh_uln_ratio": 0.9,
                  "stage_iii_or_iv": false
                },
                {
                  "age": 40,
                  "ecog": 0,
                  "extranodal_major": false,
                  "ldh_uln_ratio": 0.9,
                  "stage_iii_or_iv": false
                }
              ]
            },
            "method": "POST",
            "type": "http"
          },
          "output": {
            "example": {
              "count": 2,
              "items": [
                {
                  "age_years": 40,
                  "citation": {
                    "authors": "Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN",
                    "doi": "10.1182/blood-2013-09-524108",
                    "id": "zhou-2014",
                    "pmid": "24264230",
                    "source": "Blood. 2014;123(6):837-842",
                    "title": "An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era"
                  },
                  "components": [
                    {
                      "factor": "age",
                      "points": 0,
                      "present": false,
                      "value": 40
                    },
                    {
                      "factor": "ldh_uln_ratio",
                      "points": 0,
                      "present": false,
                      "value": 0.9
                    },
                    {
                      "factor": "stage_iii_or_iv",
                      "points": 0,
                      "present": false
                    },
                    {
                      "factor": "extranodal_major",
                      "points": 0,
                      "present": false
                    },
                    {
                      "factor": "ecog_ge_2",
                      "points": 0,
                      "present": false,
                      "value": 0
                    }
                  ],
                  "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
                  "ecog": 0,
                  "extranodal_major": false,
                  "formula": "nccn_ipi",
                  "formula_expression": "NCCN-IPI = age (≤40 0, 41–60 1, 61–75 2, ≥76 3) + LDH/ULN (≤1 0, >1–3 1, >3 2) + stage_iii_or_iv 1 + extranodal_major 1 + ecog_ge_2 1; Zhou 2014; max 8; low 0-1, low_intermediate 2-3, high_intermediate 4-5, high 6-8",
                  "ldh_uln_ratio": 0.9,
                  "max_score": 8,
                  "nccn_ipi_risk": "low",
                  "score": 0
                },
                {
                  "age_years": 40,
                  "citation": {
                    "authors": "Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN",
                    "doi": "10.1182/blood-2013-09-524108",
                    "id": "zhou-2014",
                    "pmid": "24264230",
                    "source": "Blood. 2014;123(6):837-842",
                    "title": "An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era"
                  },
                  "components": [
                    {
                      "factor": "age",
                      "points": 0,
                      "present": false,
                      "value": 40
                    },
                    {
                      "factor": "ldh_uln_ratio",
                      "points": 0,
                      "present": false,
                      "value": 0.9
                    },
                    {
                      "factor": "stage_iii_or_iv",
                      "points": 0,
                      "present": false
                    },
                    {
                      "factor": "extranodal_major",
                      "points": 0,
                      "present": false
                    },
                    {
                      "factor": "ecog_ge_2",
                      "points": 0,
                      "present": false,
                      "value": 0
                    }
                  ],
                  "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
                  "ecog": 0,
                  "extranodal_major": false,
                  "formula": "nccn_ipi",
                  "formula_expression": "NCCN-IPI = age (≤40 0, 41–60 1, 61–75 2, ≥76 3) + LDH/ULN (≤1 0, >1–3 1, >3 2) + stage_iii_or_iv 1 + extranodal_major 1 + ecog_ge_2 1; Zhou 2014; max 8; low 0-1, low_intermediate 2-3, high_intermediate 4-5, high 6-8",
                  "ldh_uln_ratio": 0.9,
                  "max_score": 8,
                  "nccn_ipi_risk": "low",
                  "score": 0
                }
              ],
              "path": "/api/calc/nccn_ipi"
            },
            "type": "json"
          }
        },
        "schema": {
          "$schema": "https://json-schema.org/draft/2020-12/schema",
          "properties": {
            "input": {
              "additionalProperties": false,
              "properties": {
                "body": {
                  "additionalProperties": false,
                  "properties": {
                    "items": {
                      "items": {
                        "properties": {
                          "age": {
                            "description": "Age in years (18-120). ≤40 scores 0; 41–60 scores 1; 61–75 scores 2; ≥76 scores 3 (Zhou 2014 NCCN-IPI refined age). Age 40 scores 0; 41 and 60 score 1; 61 and 75 score 2; 76 scores 3. Not Shipp IPI binary >60.",
                            "type": "integer"
                          },
                          "ecog": {
                            "description": "ECOG performance status 0-4 as assigned by the caller (Zhou 2014 NCCN-IPI). ≥2 scores 1. magent does not assign ECOG.",
                            "type": "integer"
                          },
                          "extranodal_major": {
                            "description": "Extranodal involvement of major organs (bone marrow, CNS, liver/GI tract, or lung) as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. This is not IPI extranodal sites >1. magent does not image extranodal sites.",
                            "type": "boolean"
                          },
                          "ldh_uln_ratio": {
                            "description": "Serum LDH divided by the laboratory ULN (0.1-20). ≤1 scores 0; >1 and ≤3 scores 1; >3 scores 2 (Zhou 2014 NCCN-IPI). 1.0 scores 0; 1.01 and 3.0 score 1; 3.01 scores 2. magent does not assay LDH.",
                            "type": "number"
                          },
                          "stage_iii_or_iv": {
                            "description": "Ann Arbor stage III or IV as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. magent does not stage lymphoma.",
                            "type": "boolean"
                          }
                        },
                        "required": [
                          "age",
                          "ecog",
                          "ldh_uln_ratio",
                          "stage_iii_or_iv",
                          "extranodal_major"
                        ],
                        "type": "object"
                      },
                      "maxItems": 25,
                      "minItems": 1,
                      "type": "array"
                    }
                  },
                  "required": [
                    "items"
                  ],
                  "type": "object"
                },
                "headers": {
                  "additionalProperties": {
                    "type": "string"
                  },
                  "type": "object"
                },
                "method": {
                  "const": "POST",
                  "type": "string"
                },
                "type": {
                  "const": "http",
                  "type": "string"
                }
              },
              "required": [
                "type",
                "method"
              ],
              "type": "object"
            },
            "output": {
              "properties": {
                "example": {
                  "type": "object"
                },
                "type": {
                  "type": "string"
                }
              },
              "required": [
                "type"
              ],
              "type": "object"
            }
          },
          "required": [
            "input"
          ],
          "type": "object"
        }
      }
    }
  },
  "liveness": {
    "reliability": null
  },
  "verified": false,
  "featured": false,
  "provider": {
    "host": "api.magentlab.com",
    "manifest_name": "api.magentlab.com",
    "source": "cdp-mirror",
    "source_manifest_url": "https://api.cdp.coinbase.com/platform/v2/x402/discovery/resources",
    "submitted_at": "2026-10-14T01:15:01.050Z"
  },
  "exampleResponse": {
    "example": {},
    "type": "string"
  }
}